Andrew Makrides, CEO at BOVIE MEDICAL CORP (BVX), sold 57,500 shares at $7.02 ($406K) on 2009-05-27, disclosed to the SEC on 2009-05-28.
Open-market sale of $406k BVX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.10 | 32,500 | $231K | 56.8% |
| 2 | $7.02 | 25,000 | $176K | 43.2% |
| Total | $7.07 avg | 57,500 | $406K | 100% |
| Filing → |